PDGFRB and neoplasm: TMPRSS2-ERG was found to associate with these factors in a manner predicting a poor outcome of the patient (high tumor stromal expression of PDGFRβ, hyaluronan, von Willebrand factor and low stromal expression of Caveolin-1) (Table 5 and 6).